SpringWorks Therapeutics' Series A Round

SpringWorks Therapeutics raised a round of funding on September 01, 2017.

SpringWorks Therapeutics is focused on underserved patient populations moving forward potential programs for four diseases (desmoid tumor, Neurofibromatosis, Hereditary xerocytosis, Post-traumatic str…

Articles about SpringWorks Therapeutics' Series A Round: